Inès Dufait
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 8
- Immunology 13
- Immunotherapy and Immune Responses 9
- Immune cells in cancer 6
- Immune Cell Function and Interaction 5
- Co-authors
- Mark De Ridder (19 shared papers)Karine Breckpot (12 shared papers)David Escors (8 shared papers)Thérèse Liechtenstein (6 shared papers)Heng Jiang (8 shared papers)Julia Katharina Schwarze (13 shared papers)Sven de Mey (6 shared papers)Alessio Lanna (5 shared papers)
- Journals
- Cancers (4 papers)International Journal of Molecular Sciences (3 papers)Oncotarget (3 papers)Radiotherapy and Oncology (3 papers)OncoImmunology (2 papers)
- Partner nations
- BelgiumUnited KingdomSpain
In The Last Decade
Inès Dufait
31 papers receiving 640 citations
Peers
Comparison fields: 5 of 67
- Immunology 259
- Oncology 236
- Cancer Research 109
- Molecular Biology 217
- Pulmonary and Respiratory Medicine 80
Countries citing papers authored by Inès Dufait
This map shows the geographic impact of Inès Dufait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inès Dufait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inès Dufait more than expected).
Fields of papers citing papers by Inès Dufait
This network shows the impact of papers produced by Inès Dufait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inès Dufait. The network helps show where Inès Dufait may publish in the future.
Co-authors
The 25 scholars most cited alongside Inès Dufait, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 78 | |
| 2 | 2015 | 57 | |
| 3 | 2012 | 39 | |
| 4 | 2012 | 39 | |
| 5 | 2016 | 36 | |
| 6 | 2014 | 35 | |
| 7 | 2018 | 33 | |
| 8 | 2016 | 33 | |
| 9 | 2023 | 26 | |
| 10 | 2023 | 26 | |
| 11 | 2022 | 24 | |
| 12 | 2020 | 24 | |
| 13 | 2021 | 23 | |
| 14 | 2013 | 23 | |
| 15 | 2020 | 20 | |
| 16 | 2013 | 18 | |
| 17 | 2022 | 17 | |
| 18 | 2024 | 16 | |
| 19 | 2019 | 16 | |
| 20 | 2023 | 12 |
About Inès Dufait
Inès Dufait is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 33 papers that have together received 644 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers), Immune cells in cancer (6 papers), Immune Cell Function and Interaction (5 papers), Virus-based gene therapy research (5 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Immunology (259 citations), Oncology (236 citations), Cancer Research (109 citations), Molecular Biology (217 citations) and Pulmonary and Respiratory Medicine (80 citations). Inès Dufait has collaborated with scholars based in Belgium, United Kingdom and Spain. Frequent co-authors include Mark De Ridder, Karine Breckpot, David Escors, Thérèse Liechtenstein, Heng Jiang, Julia Katharina Schwarze, Sven de Mey, Alessio Lanna, Thierry Gevaert and Lun Law Ka. Their work appears in journals such as Cancers, International Journal of Molecular Sciences, Oncotarget, Radiotherapy and Oncology and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.